Liu, H., Zenati, M. S., Rieser, C. J., Al-Abbas, A., Lee, K. K., Singhi, A. D., . . . Zureikat, A. H. (2020). CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer. Ann Surg Oncol.
シカゴスタイル引用形Liu, Hao, et al. "CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer." Ann Surg Oncol 2020.
MLA引用形式Liu, Hao, et al. "CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer." Ann Surg Oncol 2020.
警告: この引用は必ずしも正確ではありません.